CONNECT - DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS): DEALINGS DURING CLOSED PERIOD
Announcement Type: General Announcement
Company Name: CONNECTCOUNTY HOLDINGS BERHAD (ACE Market)
Stock Name: CONNECT
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS)
DEALINGS DURING CLOSED PERIOD
Description: We wish to inform that pursuant to Paragraph 14.08(d) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, Mr Chong Hon Keun had notified the Company of his dealing in the securities of the Company as per Table below:-
Company Name: CONNECTCOUNTY HOLDINGS BERHAD (ACE Market)
Stock Name: CONNECT
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS)
DEALINGS DURING CLOSED PERIOD
Description: We wish to inform that pursuant to Paragraph 14.08(d) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, Mr Chong Hon Keun had notified the Company of his dealing in the securities of the Company as per Table below:-
CIMBA40 - NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Announcement Type: General Announcement
Submitting Merchant Bank: DEUTSCHE BANK (MALAYSIA) BERHAD
Company Name: CIMB FTSE ASEAN 40 MALAYSIA
Stock Name: CIMBA40
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Description: Fund: CIMB FTSE ASEAN 40 Malaysia
Date: 04-May-2011
IOPV per unit (RM): 1.5914
Units in circulation (units): 8,100,000.00
Management Fee (% p.a.): 0.00
Trustee Fee (% p.a.): 0.08
Index Licence Fee (% p.a.): 0.00
FTSE/ASEAN 40 Index: 10,776.82
Submitting Merchant Bank: DEUTSCHE BANK (MALAYSIA) BERHAD
Company Name: CIMB FTSE ASEAN 40 MALAYSIA
Stock Name: CIMBA40
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Description: Fund: CIMB FTSE ASEAN 40 Malaysia
Date: 04-May-2011
IOPV per unit (RM): 1.5914
Units in circulation (units): 8,100,000.00
Management Fee (% p.a.): 0.00
Trustee Fee (% p.a.): 0.08
Index Licence Fee (% p.a.): 0.00
FTSE/ASEAN 40 Index: 10,776.82
CIMBC25 - NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Announcement Type: General Announcement
Submitting Merchant Bank: DEUTSCHE BANK (MALAYSIA) BERHAD
Company Name: CIMB FTSE CHINA 25
Stock Name: CIMBC25
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Description: Fund: CIMB FTSE China 25
Date: 04-May-2011
IOPV per unit (RM): 1.0115
Units in circulation (units): 19,500,000.00
Management Fee (% p.a.): 0.60
Trustee Fee (% p.a.): 0.08
Index Licence Fee (% p.a.): 0.04
FTSE/Xinhua China 25 Index: 19,429.99
Submitting Merchant Bank: DEUTSCHE BANK (MALAYSIA) BERHAD
Company Name: CIMB FTSE CHINA 25
Stock Name: CIMBC25
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Description: Fund: CIMB FTSE China 25
Date: 04-May-2011
IOPV per unit (RM): 1.0115
Units in circulation (units): 19,500,000.00
Management Fee (% p.a.): 0.60
Trustee Fee (% p.a.): 0.08
Index Licence Fee (% p.a.): 0.04
FTSE/Xinhua China 25 Index: 19,429.99
CMSB - GENERAL MEETINGS: OUTCOME OF MEETING
Announcement Type: General Announcement
Submitting Merchant Bank: KENANGA INVESTMENT BANK BERHAD
Company Name: CAHYA MATA SARAWAK BERHAD
Stock Name: CMSB
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: GENERAL MEETINGS
OUTCOME OF MEETING
Description: CAHYA MATA SARAWAK BERHAD ("CMS" OR THE "COMPANY")
PROPOSED ACQUISITION OF 1,000,000 ORDINARY SHARES REPRESENTING 100% EQUITY INTEREST IN CMS ROADS SDN BHD ("CMS ROADS") AND 5,000,000 ORDINARY SHARES REPRESENTING 100% EQUITY INTEREST IN CMS PAVEMENT TECH SDN BHD ("CMS PAVEMENT") FROM PUTRAJAYA PERDANA BERHAD ("PPB") FOR A TOTAL CASH CONSIDERATION OF RM82,007,766 ("PROPOSED ACQUISITION").
Submitting Merchant Bank: KENANGA INVESTMENT BANK BERHAD
Company Name: CAHYA MATA SARAWAK BERHAD
Stock Name: CMSB
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: GENERAL MEETINGS
OUTCOME OF MEETING
Description: CAHYA MATA SARAWAK BERHAD ("CMS" OR THE "COMPANY")
PROPOSED ACQUISITION OF 1,000,000 ORDINARY SHARES REPRESENTING 100% EQUITY INTEREST IN CMS ROADS SDN BHD ("CMS ROADS") AND 5,000,000 ORDINARY SHARES REPRESENTING 100% EQUITY INTEREST IN CMS PAVEMENT TECH SDN BHD ("CMS PAVEMENT") FROM PUTRAJAYA PERDANA BERHAD ("PPB") FOR A TOTAL CASH CONSIDERATION OF RM82,007,766 ("PROPOSED ACQUISITION").
BANENG - OTHERS (Amended Announcement)
Announcement Type: General Announcement
Company Name: BANENG HOLDINGS BHD
Stock Name: BANENG
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: OTHERS
Description: Deviation between Audited and Unaudited Results for the financial year ended 31 December 2010
Company Name: BANENG HOLDINGS BHD
Stock Name: BANENG
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: OTHERS
Description: Deviation between Audited and Unaudited Results for the financial year ended 31 December 2010
KPJ - OTHERS
Announcement Type: General Announcement
Submitting Merchant Bank: AFFIN INVESTMENT BANK BERHAD
Company Name: KPJ HEALTHCARE BERHAD
Stock Name: KPJ
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: OTHERS
Description: KPJ HEALTHCARE BERHAD ("KPJ " OR "COMPANY")
PROPOSED ISSUE OF, OFFER FOR SUBSCRIPTION OR PURCHASE OF, OR INVITATION TO SUBSCRIBE FOR OR PURCHASE OF ISLAMIC COMMERCIAL PAPERS ("ICP")/ ISLAMIC MEDIUM TERM NOTES ("IMTN") OF UP TO RM500.0 MILLION IN NOMINAL VALUE ("ICP/IMTN PROGRAMME") BY POINT ZONE (M) SDN BHD ("POINT ZONE"), A 100% OWNED SUBSIDIARY OF KPJ
Submitting Merchant Bank: AFFIN INVESTMENT BANK BERHAD
Company Name: KPJ HEALTHCARE BERHAD
Stock Name: KPJ
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: OTHERS
Description: KPJ HEALTHCARE BERHAD ("KPJ " OR "COMPANY")
PROPOSED ISSUE OF, OFFER FOR SUBSCRIPTION OR PURCHASE OF, OR INVITATION TO SUBSCRIBE FOR OR PURCHASE OF ISLAMIC COMMERCIAL PAPERS ("ICP")/ ISLAMIC MEDIUM TERM NOTES ("IMTN") OF UP TO RM500.0 MILLION IN NOMINAL VALUE ("ICP/IMTN PROGRAMME") BY POINT ZONE (M) SDN BHD ("POINT ZONE"), A 100% OWNED SUBSIDIARY OF KPJ
AXIATA - OTHERS
Announcement Type: General Announcement
Submitting Merchant Bank: N/A
Company Name: AXIATA GROUP BERHAD
Stock Name: AXIATA
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: OTHERS
Description: ENTRY INTO A SHAREHOLDERS AGREEMENT BY DIALOG AXIATA PLC, A 84.97% SUBSIDIARY COMPANY OF AXIATA GROUP BERHAD ("AXIATA"), AND ITS WHOLLY-OWNED SUBSIDIARY COMPANY, DIALOG BUSINESS SERVICES (PRIVATE) LIMITED WITH FIRSTSOURCE SOLUTIONS LIMITED
Submitting Merchant Bank: N/A
Company Name: AXIATA GROUP BERHAD
Stock Name: AXIATA
Date Announced: 04/05/2011
Announcement Detail:
Type: Announcement
Subject: OTHERS
Description: ENTRY INTO A SHAREHOLDERS AGREEMENT BY DIALOG AXIATA PLC, A 84.97% SUBSIDIARY COMPANY OF AXIATA GROUP BERHAD ("AXIATA"), AND ITS WHOLLY-OWNED SUBSIDIARY COMPANY, DIALOG BUSINESS SERVICES (PRIVATE) LIMITED WITH FIRSTSOURCE SOLUTIONS LIMITED
PHARMA - Change in Audit Committee
Announcement Type: Change in Audit Committee
Company Name: PHARMANIAGA BERHAD
Stock Name: PHARMA
Date Announced: 04/05/2011
Announcement Detail:
Date of change: 03/05/2011
Type of change: Appointment
Designation: Member of Audit Committee
Directorate: Independent & Non Executive
Name: Izzat bin Othman
Age: 50
Nationality: Malaysian
Qualifications: LLB (Hons), University of Malaya
Working experience and occupation: Encik Izzat is a lawyer by profession and is a partner of the law firm of Azzat & Izzat.
He was admitted as an Advocate and Solicitor on 25 January 1986.
Encik Izzat was formerly a director in AFFIN Securities Sdn Bhd and BH Insurance (M) Berhad and has vast experience relating to litigation, conveyancing and corporate matters.
He sits as a Chairman and committee member of the Disciplinary Committee of the Malaysian Bar.
Directorship of public companies (if any): Nil
Family relationship with any director and/or major shareholder of the listed issuer: Nil
Any conflict of interests that he/she has with the listed issuer: Nil
Details of any interest in the securities of the listed issuer or its subsidiaries: Nil
Composition of Audit Committee (Name and Directorate of members after change): 1. Mohd Suffian bin Hj. Haron (Chairman)
2. Ebinesan @ Daniel a/l Gnanakkan
3. Izzat bin Othman
Company Name: PHARMANIAGA BERHAD
Stock Name: PHARMA
Date Announced: 04/05/2011
Announcement Detail:
Date of change: 03/05/2011
Type of change: Appointment
Designation: Member of Audit Committee
Directorate: Independent & Non Executive
Name: Izzat bin Othman
Age: 50
Nationality: Malaysian
Qualifications: LLB (Hons), University of Malaya
Working experience and occupation: Encik Izzat is a lawyer by profession and is a partner of the law firm of Azzat & Izzat.
He was admitted as an Advocate and Solicitor on 25 January 1986.
Encik Izzat was formerly a director in AFFIN Securities Sdn Bhd and BH Insurance (M) Berhad and has vast experience relating to litigation, conveyancing and corporate matters.
He sits as a Chairman and committee member of the Disciplinary Committee of the Malaysian Bar.
Directorship of public companies (if any): Nil
Family relationship with any director and/or major shareholder of the listed issuer: Nil
Any conflict of interests that he/she has with the listed issuer: Nil
Details of any interest in the securities of the listed issuer or its subsidiaries: Nil
Composition of Audit Committee (Name and Directorate of members after change): 1. Mohd Suffian bin Hj. Haron (Chairman)
2. Ebinesan @ Daniel a/l Gnanakkan
3. Izzat bin Othman
PHARMA - Change in Audit Committee
Announcement Type: Change in Audit Committee
Company Name: PHARMANIAGA BERHAD
Stock Name: PHARMA
Date Announced: 04/05/2011
Announcement Detail:
Date of change: 03/05/2011
Type of change: Appointment
Designation: Member of Audit Committee
Directorate: Non Independent & Non Executive
Name: Ebinesan @ Daniel a/l Gnanakkan
Age: 66
Nationality: Malaysian
Qualifications: Fellow of the Chartered Institute of Management Accountants
Member of the Malaysian Institue of Certified Public Accountants
Member of the Malaysian Institute of Accountants
Working experience and occupation: Mr. Daniel Ebinesan is currently Director,Financial Services of Boustead Holdings Berhad.
He joined the Boustead Holdings Berhad Group on 1 April 1974 as the Group Accountant. He was promoted to Group Chief Accountant on 1 January 1982 and on 1 January 1993, to General Manager, Finance & Administration. On July 1996, he assumed the role of Chief Financial Officer of the Boustead Group.
Directorship of public companies (if any): Nil
Family relationship with any director and/or major shareholder of the listed issuer: Nil
Any conflict of interests that he/she has with the listed issuer: Nil
Details of any interest in the securities of the listed issuer or its subsidiaries: Nil
Composition of Audit Committee (Name and Directorate of members after change): 1. Mohd Suffian bin Hj. Haron (Chairman)
2. Ebinesan @ Daniel a/l Gnanakkan
3. Izzat bin Othman
Company Name: PHARMANIAGA BERHAD
Stock Name: PHARMA
Date Announced: 04/05/2011
Announcement Detail:
Date of change: 03/05/2011
Type of change: Appointment
Designation: Member of Audit Committee
Directorate: Non Independent & Non Executive
Name: Ebinesan @ Daniel a/l Gnanakkan
Age: 66
Nationality: Malaysian
Qualifications: Fellow of the Chartered Institute of Management Accountants
Member of the Malaysian Institue of Certified Public Accountants
Member of the Malaysian Institute of Accountants
Working experience and occupation: Mr. Daniel Ebinesan is currently Director,Financial Services of Boustead Holdings Berhad.
He joined the Boustead Holdings Berhad Group on 1 April 1974 as the Group Accountant. He was promoted to Group Chief Accountant on 1 January 1982 and on 1 January 1993, to General Manager, Finance & Administration. On July 1996, he assumed the role of Chief Financial Officer of the Boustead Group.
Directorship of public companies (if any): Nil
Family relationship with any director and/or major shareholder of the listed issuer: Nil
Any conflict of interests that he/she has with the listed issuer: Nil
Details of any interest in the securities of the listed issuer or its subsidiaries: Nil
Composition of Audit Committee (Name and Directorate of members after change): 1. Mohd Suffian bin Hj. Haron (Chairman)
2. Ebinesan @ Daniel a/l Gnanakkan
3. Izzat bin Othman
PHARMA - Change in Audit Committee
Announcement Type: Change in Audit Committee
Company Name: PHARMANIAGA BERHAD
Stock Name: PHARMA
Date Announced: 04/05/2011
Announcement Detail:
Date of change: 03/05/2011
Type of change: Appointment
Designation: Chairman of Audit Committee
Directorate: Independent & Non Executive
Name: Mohd Suffian bin Hj. Haron
Age: 65
Nationality: Malaysian
Qualifications: Master in Business Administration, University of Oregon, United States of America
Bachelor in Economics, University of Malaya
Working experience and occupation: En. Mohd Suffian started his career as a Diplomatic and Administrative Officer, attached to the Implementation and Coordination Unit of the Prime Minister's Department and left the Government (after 13 years of service), and served a Government-Linked Company for 6 years.
He has vast experience in the insurance, financial, securities and asset management sectors as well as trading, energy, oil and gas industry.
Directorship of public companies (if any): Affin Bank Berhad
Affin Islamic Bank Berhad
Family relationship with any director and/or major shareholder of the listed issuer: Nil
Any conflict of interests that he/she has with the listed issuer: Nil
Details of any interest in the securities of the listed issuer or its subsidiaries: Nil
Composition of Audit Committee (Name and Directorate of members after change): 1. Mohd Suffian bin Hj. Haron (Chairman)
2. Ebinesan @ Daniel a/l Gnanakkan
3. Izzat bin Othman
Company Name: PHARMANIAGA BERHAD
Stock Name: PHARMA
Date Announced: 04/05/2011
Announcement Detail:
Date of change: 03/05/2011
Type of change: Appointment
Designation: Chairman of Audit Committee
Directorate: Independent & Non Executive
Name: Mohd Suffian bin Hj. Haron
Age: 65
Nationality: Malaysian
Qualifications: Master in Business Administration, University of Oregon, United States of America
Bachelor in Economics, University of Malaya
Working experience and occupation: En. Mohd Suffian started his career as a Diplomatic and Administrative Officer, attached to the Implementation and Coordination Unit of the Prime Minister's Department and left the Government (after 13 years of service), and served a Government-Linked Company for 6 years.
He has vast experience in the insurance, financial, securities and asset management sectors as well as trading, energy, oil and gas industry.
Directorship of public companies (if any): Affin Bank Berhad
Affin Islamic Bank Berhad
Family relationship with any director and/or major shareholder of the listed issuer: Nil
Any conflict of interests that he/she has with the listed issuer: Nil
Details of any interest in the securities of the listed issuer or its subsidiaries: Nil
Composition of Audit Committee (Name and Directorate of members after change): 1. Mohd Suffian bin Hj. Haron (Chairman)
2. Ebinesan @ Daniel a/l Gnanakkan
3. Izzat bin Othman
No comments:
Post a Comment